Post-earnings recap
Reported
Thu, Aug 7, 2025
EPS actual
$-0.10
EPS est.
$-0.13
EPS surprise
+21.26%
1-day move
-0.96%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Corvus Pharmaceuticals reported a narrower loss than expected, with an EPS of $-0.10, which was a positive surprise. However, the stock reacted negatively, declining by 0.96%. The lack of revenue data and guidance may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.10 | N/A | +21.26% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.